Navidea Biopharmaceuticals Schedules Third Quarter 2017 Earnings Conference Call and Business Update

Oct 31, 2017

Navidea Signs Letter of Intent to Sublicense NAV4694 Worldwide Development Rights

Oct 27, 2017

Navidea Biopharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Sep 8, 2017

Navidea To Initiate Regular Webcast Series Featuring Moderated Q&A with Management

Aug 30, 2017

Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results

Aug 8, 2017

Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics

Jun 20, 2017

Navidea’s Commercial Partner, Norgine B.V., Launches LYMPHOSEEK® in Europe

Jun 12, 2017

Navidea Biopharmaceuticals to Present at the 7th Annual LD Micro Invitational Investor Conference

Jun 1, 2017

Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results

May 9, 2017

Navidea Biopharmaceuticals Invited to Present Data at Two Major Upcoming Conferences

Apr 25, 2017